-Dennis D Weisenburger Researcher Activity Profile

Research Author Detailed Information 

Dennis D Weisenburger Publication Rate By Year

Dennis D Weisenburger has published 1 paper(s) in 2006, 21 paper(s) in 2007, for a total of 22 research publications in total.

Dennis D Dd Weisenburger Author Information

LAST NAME: weisenburger

FIRST NAME: Dennis D

INITIALS: dd

AFFILIATION:

Papers

Dennis D Weisenburger's Publication Record

1. Ortho-quinones of benzene and estrogens induce hyperproliferation of human peripheral blood mononuclear cells. Year Published: 2006
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
2. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. Year Published: 2007
Department of Pathology and Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain.
3. Frequent occurrence of deletions in primary mediastinal B-cell lymphoma. Year Published: 2007
Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
4. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Year Published: 2007
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852, USA. mortonli@mail.nih.gov
5. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation. Year Published: 2007
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. dljaye@emory.edu
6. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. Year Published: 2007
Department of Genetics, University of Nebraska Medical Center, Omaha, NE 68198-6395, USA.
7. Frequent occurrence of deletions in primary mediastinal B-cell lymphoma. Year Published: 2007
Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
8. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Year Published: 2007
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
9. Sun exposure and non-Hodgkin lymphoma: A population-based, case-control study. Year Published: 2007
Department of Preventive Medicine, Northwestern University Medical School, Chicago, IL, United States.
10. Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis. Year Published: 2007
DCEG/Radiation Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA. linetm@mail.nih.gov
11. Chemical exposures and risk of chronic lymphocytic leukaemia. Year Published: 2007
Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. blaira@mail.nih.gov
12. Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma. Year Published: 2007
13. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation. Year Published: 2007
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. dljaye@emory.edu
14. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. Year Published: 2007
Department of Genetics, University of Nebraska Medical Center, Omaha, NE 68198-6395, USA.
15. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Year Published: 2007
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
16. Frequent occurrence of deletions in primary mediastinal B-cell lymphoma. Year Published: 2007
Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
17. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index. Year Published: 2007
Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198-7680, USA. jmvose@unmc.edu
18. Sun exposure and non-Hodgkin lymphoma: a population-based, case-control study. Year Published: 2007
Department of Preventive Medicine, Northwestern University Medical School, Chicago, IL, United States.
19. Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma. Year Published: 2007
Department of Pathology and Microbiology, Munroe Meyer Institute for Genetics and Rehabilitation, Omaha, NE, USA.
20. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index. Year Published: 2007
Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198-7680, USA. jmvose@unmc.edu
21. Sun exposure and non-Hodgkin lymphoma: a population-based, case-control study. Year Published: 2007
Department of Preventive Medicine, Northwestern University Medical School, Chicago, IL, United States.
22. Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma. Year Published: 2007
Department of Pathology and Microbiology, Munroe Meyer Institute for Genetics and Rehabilitation, Omaha, NE, USA.